Close
The information provided in this website is intended for US healthcare professionals only.
I certify that I am a US healthcare professional.
RETAVASE® (reteplase) is a tissue plasminogen activator (tPA) indicated for treatment of acute ST-elevation myocardial infarction (STEMI) to reduce the risk of death and heart failure.
Limitation of Use: The risk of stroke may outweigh the benefit produced by thrombolytic therapy in patients whose STEMI puts them at low risk for death or heart failure.